Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Total RNA expression in response to TGF-beta treatment in HepG2 cells

ABSTRACT: Total RNA expression in response to TGF-beta treatment in HepG2 cells

PROVIDER: PRJEB4495 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR329495.fastq.gz	Fastqsanger.gz
	ERR329496.fastq.gz	Fastqsanger.gz
	ERR329497.fastq.gz	Fastqsanger.gz
	ERR329498.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

HNF4A-binding sites in HepG2 hepatoblastoma cells treated with TGF-beta

Project description:Specific regulation of target genes by transforming growth factor-β (TGF-β) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In the present study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of known genes in HepG2 hepatoblastoma cells, and compared them to those in HaCaT epidermal keratinocytes to elucidate the mechanisms of cell type- and context-dependent regulation of transcription induced by TGF-β. Our results show that 81% of the Smad2/3 binding regions in HepG2 cells were not shared with those found in HaCaT cells. Hepatocyte nuclear factor 4α (HNF4α) is expressed in HepG2 cells, but not in HaCaT cells, and the HNF4α binding motif was identified as an enriched motif in the HepG2-specific Smad2/3 binding regions. ChIP-sequencing analysis of HNF4A binding regions under TGF-β stimulation revealed that 32.5% of the Smad2/3 binding regions overlapped HNF4A bindings. MIXL1 was identified as a new combinatorial target of HNF4A and Smad2/3, and both the HNF4A protein and its binding motif were required for the induction of MIXL1 by TGF-β in HepG2 cells. These findings generalize the importance of binding of HNF4A on Smad2/3 binding genomic regions for HepG2-specific regulation of transcription by TGF-β, and suggest that certain transcription factors expressed in a cell-type-specific manner play important roles in the transcription regulated by the TGF-β-Smad signaling pathway. HepG2 cells were treated with TGF-beta for 1.5 h or left untreated. anti-HNF4A ChIP-seq was performed. One lane was used for each sample.

2011-06-08 | E-GEOD-28845 | biostudies-arrayexpress

Expression data of the human hepatoblastoma cell line HepG2 treated with TGF-beta

Project description:Smad2/3 are transcription factors that engage in TGF-beta-induced transcription. We determined and analyzed HepG2 and Hep3B-specific Smad2/3 binding sites by ChIP-chip. We used expression microarrays to compare the Smad2/3 and HNF4alpha binding sites identified by ChIP-chip or ChIP-seq, respectively, to TGF-beta-induced gene expressions. HepG2 cells were transfected with control or HNF4A siRNAs and treated with 3 ng/ml TGF-beta for 0, 1.5 and 24 h (6 samples in total, no replicates). Total RNA was extracted and expression microarray analysis was performed as described in the protocols.

2011-06-08 | E-GEOD-28590 | biostudies-arrayexpress

Nucleosome regulatory dynamics in response to TGF-beta treatment in HepG2 cells

Project description:Nucleosome regulatory dynamics in response to TGF-beta treatment in HepG2 cells

| PRJEB4473 | ENA

Total RNA expression in response to TGF-beta treatment in HepG2 cells

Project description:We used RNA-sequencing to examine expression patterns before and after treatment with TGFB growth factor for 1h in HepG2-cells.

2014-04-30 | E-MTAB-1819 | biostudies-arrayexpress

HNF4A-binding sites in HepG2 hepatoblastoma cells treated with TGF-beta

2011-06-08 | GSE28845 | GEO

TGF-beta1-Induced Gene Expression Changes in HepG2 Cells

Project description:We here compared gene expression profiles in HepG2 cells upon stimulation with 1 ng/ml TGF-beta1 for 20 min, 1 hour, 2 hours, 4 hours, and 24 hours with untreated control cells. Experiments were done in three independent replicates. The goal of this study was to determine genes regulated by TGF-beta1.HepG2 cells were obtained from DSMZ (Braunschweig, Germany) and cell identity confirmed by STR profiling using the AmpFlSTR Identfiler Direct PCR Amplification kit (Life Technologies, Darmstadt, Germany). Gene expression profiles were compared at indicated time points after stimulation with TGF-beta (1 ng/ml) using the Human Gene 1.0 ST arrays (Affymetrix). In total 18 hybridizations are included in this series. 18 samples were hybridized to Affymetrix Human Gene 1.0 ST Array

2013-04-10 | E-GEOD-45945 | biostudies-arrayexpress

Expression data of the human hepatoblastoma cell line HepG2 treated with TGF-beta

2011-06-08 | GSE28590 | GEO

Gene expression analysis of PJA1 knock down HepG2 cells or HepG2 cells treated with TGF-beta1.

Project description:Gene expression profiling was carried out in four (HepG2-shCtrl,HepG2-shPJA1, HepG2/Ctrl and HepG2/TGFb1 cells) different liver cancer cells. PJA1 is an E3 ligase that regulates TGF-beta signaling pathway. In this study, we report a major role of the PJA1-mediated desregulation of TGF-beta/Smad3 in liver cancers . To determine the mechanism for the oncogenic function of PJA1 in TGF-β signaling transduction, we analyzed gene profiles the cells of knockdown PJA1 in HepG2 cells and the cells treated with TGFb1 in HepG2.

2022-06-13 | GSE132723 | GEO

TGF-beta and TLR4-induced transcriptional response

Project description:To assess the pattern of TGF-beta and TLR4-induced gene expression changes at the genome-wide level, confluent healthy skin fibroblasts were incubated with the classic TLR4 ligand, LPS, TGF-beta or transfected with CD4TLR4. At the end of incubation, total RNA was harvested and processed for hybridizations to Illumina Human HT-12V4 microarray chips.

2016-04-23 | GSE79621 | GEO

Nucleosome regulatory dynamics in response to TGF-beta treatment in HepG2 cells

Project description:We used ultra deep sequencing of MnaseI trated cells to faithfully position nucleosomes before and after treatment with TGFB growth factor for 1h in HepG2-cells.

2014-04-30 | E-MTAB-1750 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data